Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:http://oc1dean.blogspot.com/2010/11/my-background-story_8.html

Thursday, August 10, 2017

New aspects of stroke medicine

Someplace in here there should be a protocol that all stroke hospitals should be following. And since this is 3 years old this should have been updated multiple times since then based upon newer research.  But I bet YOU will have to bring this information to your stroke emergency room doctors.  Good luck out there.
http://search.naric.com/research/rehab/redesign_record.cfm?search=2&type=all&criteria=I243296&phrase=no&rec=243296&article_source=CIRRIE&international=1&international_language=&international_location=
Neues aus der Schlaganfallmedizin.  Der Nervenarzt , Volume 85(8) , Pgs. 939-945.

NARIC Accession Number: I243296.  What's this?
Author(s): H.C. Diener ; B. Frank; K. Hajjar ; C. Weimar.
Publication Year: 2014.
Abstract: This article provides an overview of new treatment options in stroke medicine. Systemic thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) remains the only effective and approved medical treatment of acute ischemic stroke. Several studies have demonstrated the importance of rapid recanalization. The efficacy of thrombectomy has so far not been sufficiently shown in randomized clinical trials; therefore, inclusion of suitable patients in one of the currently ongoing randomized trials is of great importance. The early treatment with magnesium after acute ischemic stroke during the pre-hospital phase did not prove to be neuroprotective. Intermittent pneumatic compression of the lower extremities in immobilized stroke patients effectively prevents deep venous thrombosis and pulmonary embolism. In patients with lacunar stroke, the combination of aspirin and clopidogrel is not superior to aspirin alone and causes more bleeding complications. The novel oral anticoagulants are superior to warfarin in secondary prevention and carry a lower risk of intracranial and systemic bleeding compli­cations. New studies will investigate whether dabigatran or rivaroxaban are superior to aspirin in secondary prevention after cryptogenic stroke.
Descriptor Terms: Clinical trials, Drugs, Stroke.
Language: German
Geographic Location(s): Europe, Germany.

Can this document be ordered through NARIC's document delivery service*?: Request Information.
Get this Document: http://dx.doi.org/10.1007/s00115-014-4036-4 .

Citation: H.C. Diener , B. Frank, K. Hajjar , C. Weimar. (2014). New aspects of stroke medicine.  Neues aus der Schlaganfallmedizin.  Der Nervenarzt , 85(8), Pgs. 939-945. Retrieved 8/10/2017, from REHABDATA database.

No comments:

Post a Comment